PCRX
insider transactionsPacira BioSciences, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-16.4K
0 buy · 16.4K sell
Net value · 30d
-$372.2K
$0 in · $372.2K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
2
0 buy · 16.4K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
2.0K sh
Own New
-
Grant·A
Director
$0
3.8K sh
Own New
-
Sell·S
Lauren Riker KEY
Senior Vice President, Finance · 10b5-1
$143.7K
6.1K sh · $23.50
Own -9%
-
Grant·A
Director
$0
32.7K sh
Own New
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +56%
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +48%
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own New
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +32%
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +38%
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +27%
-
Grant·A
Director
$0
10.9K sh
Own New
-
Grant·A
Director
$0
6.4K sh
Own +56%
-
Grant·A
Director
$0
16.4K sh
Own New
-
Sell·S
Chief Administrative Officer · 10b5-1
$228.5K
10.3K sh · $22.27
Own -6%
-
Other·F
Lauren Riker KEY
Senior Vice President, Finance
$71.1K
3.2K sh · $22.32
Own -4%
-
Other·F
Chief Medical Officer
$105.5K
4.7K sh · $22.32
Own -2%
-
Other·F
Chief Administrative Officer · 10b5-1
$190.3K
8.5K sh · $22.32
Own -5%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Laura Brege | Grant A | 2.0K | $0 |
| Jun 15, 2026 | Laura Brege | Grant A | 3.8K | $0 |
| Jun 11, 2026 | Lauren Riker KEY 10b5-1 | Sell S | 6.1K | $143.7K |
| Jun 10, 2026 | Thomas G Wiggans | Grant A | 32.7K | $0 |
| Jun 10, 2026 | Alethia Young | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Alethia Young | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Michael J. Yang | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Michael J. Yang | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Samit Hirawat | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Samit Hirawat | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Mark Froimson | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Mark Froimson | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Christopher Christie | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Christopher Christie | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Laura Brege | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Laura Brege | Grant A | 6.4K | $0 |
| Jun 10, 2026 | Marcelo Bigal | Grant A | 10.9K | $0 |
| Jun 10, 2026 | Marcelo Bigal | Grant A | 6.4K | $0 |
| Jun 5, 2026 | Laura Brege | Grant A | 16.4K | $0 |
| Jun 4, 2026 | Kristen Williams 10b5-1 | Sell S | 10.3K | $228.5K |
| Jun 3, 2026 | Lauren Riker KEY | Other F | 3.2K | $71.1K |
| Jun 3, 2026 | Jonathan Slonin | Other F | 4.7K | $105.5K |
| Jun 3, 2026 | Kristen Williams 10b5-1 | Other F | 8.5K | $190.3K |
About PCRX insider trading
This page tracks insider transactions for Pacira BioSciences, Inc. (PCRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.